TRAF2 and melanoma: In IFNγ-resistant melanoma cells, TRAF2 and cIAP1 were identified as key factors increasing sensitivity to CD8 + T-cell mediated killing by lowering the TNF cytotoxicity threshold and, therefore, increasing immunotherapy efficacy.